New therapeutic approach for nasopharyngeal carcinoma using induction of Epstein-Barr virus lytic cycle by anti-cancer chemotherapy
Project/Area Number |
20592012
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Otorhinolaryngology
|
Research Institution | Kanazawa University |
Principal Investigator |
MURONO Shigeyuki Kanazawa University, 附属病院, 講師 (20345622)
|
Co-Investigator(Renkei-kenkyūsha) |
YOSHIZAKI Tomokazu 金沢大学, 医学系, 教授 (70262582)
WAKISAKA Naohiro 金沢大学, 附属病院, 講師 (70377414)
KONDO Satoru 金沢大学, 附属病院, 助教 (70436822)
|
Project Period (FY) |
2008 – 2010
|
Project Status |
Completed (Fiscal Year 2010)
|
Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2010: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2009: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2008: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | 上咽頭癌 / 抗癌剤 / EBウイルス / 複製サイクル / ガンシクロビル |
Research Abstract |
Treatment of Epstein-Barr virus-positive epithelial cell lines with CDDP, one of anti-cancer drugs, induced BZLF1 protein, which play an important role in switching latent EBV infection to lytic cycle. No clear induction of apoptosis by the drug was observed. In the biopsy specimens taken from post-chemotherapy nasopharyngeal carcinoma patients, histological effect of chemotherapy was grade 0 or 1. On the other hand, immunohistochemistry for BZLF1 could not be properly performed.
|
Report
(4 results)
Research Products
(12 results)
-
-
-
-
-
-
-
-
[Presentation] 当科における上咽頭癌症例の検討2010
Author(s)
加藤理紗, 遠藤一平, 近藤悟, 脇坂尚宏, 室野重之, 吉崎智一
Organizer
第34回日本頭頸部癌学会
Place of Presentation
京王プラザホテル(東京都)
Year and Date
2010-06-11
Related Report
-
-
-
-